Rusfertide

PTG-300 · Protagonist Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Rusfertide, covering 2025-08-06 to 2025-08-07. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera [Phase 3]